José de Jesús Rodríguez Aleriano

Dr. José de Jesús Rodríguez Aleriano


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2026 in Cosmetics
Verified
Journal Article
Open access
PDF file
JAJosé de Jesús Rodríguez Aleriano
José de Jesús Rodríguez Aleriano
OCOdessa Magallon Chavez
Odessa Magallon Chavez
JNJOSE NAVARRO
JOSE NAVARRO
LMLuisa Fernanda Briones Márquez
Luisa Fernanda Briones Márquez
ELEdgar J López-Naranjo
Edgar J López-Naranjo
JLJuan Antonio Rivas Loaiza
Juan Antonio Rivas Loaiza
Polydeoxyribonucleotide (PDRN) has emerged as a promising bioactive biomaterial with broad applications in regenerative medicine because of its anti-inflammatory, angiogenic, and tissue-repair properties. Traditionally obtained from salmonid sperm DNA, it has been reported to promote tissue regeneration primarily by activating adenosine A2A receptors and the nucleotide salvage pathway, thereby stimulating fibroblast proliferation, extracellular matrix remodeling, collagen synthesis, and angiogenesis. This review provides a comprehensive overview of the biochemical characteristics, mechanisms of action, extraction methods, and translational potential of PDRN from different biological sources. In addition to conventional animal-derived PDRN, recent advances have introduced plant-derived (PhytoPDRN) and microbial- or algae-derived alternatives, offering improved sustainability, scalability, and reduced environmental impact. Preliminary in vitro evidence suggests that these emerging sources may exhibit regenerative and antioxidant activities; however, differences in molecular characteristics, experimental models, and study designs currently preclude establishing biological or clinical equivalence with salmon-derived PDRN. Finally, the translational perspectives, industrial challenges, and future research directions are analyzed, highlighting the need for standardized manufacturing processes, comparative clinical trials, and sustainable production strategies. Overall, PDRN is a DNA-derived biomaterial of growing interest in regenerative medicine and cosmetic applications. At the same time, novel biological sources may contribute to the development of more sustainable and clinically effective next-generation PDRN-based therapies.